Share on LinkedInShare on LinkedIn

ARTICLE · 03 JUNE 2015

Implementation Of Teva's Hybrid Review Claim Construction

Addressing the issue of de novo versus differential claim construction review post-Teva, the Supreme Court of the United States remanded back to the U.S. Court of Appeals for the Federal Circuit a case where de novo review was applied to a disputed claim term.

United StatesIntellectual Property

CSR PLC v. Azure Networks, LLC

Addressing the issue of de novo versus differential claim construction review post-Teva, the Supreme Court of the United States remanded back to the U.S. Court of Appeals for the Federal Circuit a case where de novo review was applied to a disputed claim term. CSR PLC v. Azure Networks, LLC, Case No. 14-976 (Supr. Ct., Apr. 20, 2015). 

In January 2015, the Supreme Court ruled in Teva v. Sandoz that the Federal Circuit must generally apply a "clear error" standard when reviewing a district court's claim construction that is not based on intrinsic claim construction evidence ( IP Update , Vol. 18, No. 1).

In the present case, the plaintiff Azure Networks sued CSR, alleging that the defendant's products infringed Azure's patent on Bluetooth technology. After the district court construed the patent term "MAC address," the district court entered judgment in favor of CSR, finding non-infringement of the Azure patent. Azure appealed,

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from